Emerging Aedes-borne infections in southern Switzerland: Preparedness planning for surveillance and intervention.

Aedes albopictus Arboviruses Canton Ticino Emergency Preparedness plan

Journal

Travel medicine and infectious disease
ISSN: 1873-0442
Titre abrégé: Travel Med Infect Dis
Pays: Netherlands
ID NLM: 101230758

Informations de publication

Date de publication:
Historique:
received: 13 08 2019
revised: 01 12 2019
accepted: 18 05 2020
pubmed: 28 7 2020
medline: 21 8 2021
entrez: 27 7 2020
Statut: ppublish

Résumé

The Preparedness Plan for Surveillance and Interventions on Emerging Vector-Borne Diseases (VBDs) in Southern Switzerland outlines the strategy for preventing and managing potential outbreaks, as well as the surveillance and control activities with a specific focus on Aedes-borne diseases transmitted by Aedes albopictus mosquitoes. The objective of the plan is to provide Public Health Authorities with a framework of preventive and control measures according to the situation and level of epidemic risks. The plan is divided into various phases representing the different steps for all potential situations, ranging from no vectors and no transmission risk to epidemic levels with multiple autochthonous/local cases of hospitalization (and deaths) until the end of the epidemic. An algorithm presents how decisions are taken to move from one phase of the plan to another, with detailed activities for different partners and strategies for each specific phase. The different phases of the plan include activities on disease surveillance and clinical case management, on vector surveillance and control, communication and coordination of activities. The plan is divided into five phases of activities and decision levels. From phase 0 (no cases) to phase 1 (low number of local cases, less than 5), phase 2 (small outbreak with more than 5 local cases), phase 3 (epidemic) and phase 4 (return to no more cases). The plan has been approved by the cantonal authorities and will be submitted to federal authorities. The required implementation tests will begin shortly.

Sections du résumé

BACKGROUND
The Preparedness Plan for Surveillance and Interventions on Emerging Vector-Borne Diseases (VBDs) in Southern Switzerland outlines the strategy for preventing and managing potential outbreaks, as well as the surveillance and control activities with a specific focus on Aedes-borne diseases transmitted by Aedes albopictus mosquitoes. The objective of the plan is to provide Public Health Authorities with a framework of preventive and control measures according to the situation and level of epidemic risks.
MATERIAL AND METHODS
The plan is divided into various phases representing the different steps for all potential situations, ranging from no vectors and no transmission risk to epidemic levels with multiple autochthonous/local cases of hospitalization (and deaths) until the end of the epidemic. An algorithm presents how decisions are taken to move from one phase of the plan to another, with detailed activities for different partners and strategies for each specific phase.
RESULTS
The different phases of the plan include activities on disease surveillance and clinical case management, on vector surveillance and control, communication and coordination of activities. The plan is divided into five phases of activities and decision levels. From phase 0 (no cases) to phase 1 (low number of local cases, less than 5), phase 2 (small outbreak with more than 5 local cases), phase 3 (epidemic) and phase 4 (return to no more cases).
CONCLUSION
The plan has been approved by the cantonal authorities and will be submitted to federal authorities. The required implementation tests will begin shortly.

Identifiants

pubmed: 32712264
pii: S1477-8939(20)30227-1
doi: 10.1016/j.tmaid.2020.101748
pmc: PMC7593978
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

101748

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

Copyright © 2020. Published by Elsevier Ltd.

Références

Niger Med J. 2017 Jan-Feb;58(1):1-6
pubmed: 29238121
Clin Microbiol Infect. 2018 Mar;24(3):221-228
pubmed: 29274465
Eur J Epidemiol. 1997 Feb;13(2):209-15
pubmed: 9085007
BMC Infect Dis. 2017 Mar 16;17(1):216
pubmed: 28302072
New Microbiol. 2015 Jan;38(1):97-100
pubmed: 25821943
Parasit Vectors. 2019 Nov 21;12(1):554
pubmed: 31753035
Lancet. 2007 Dec 1;370(9602):1840-6
pubmed: 18061059
Med Vet Entomol. 2020 Jun;34(2):244-250
pubmed: 31802522
J Bus Contin Emer Plan. 2016 Spring;9(3):281-90
pubmed: 26897624
Parasit Vectors. 2015 Apr 09;8:208
pubmed: 25890173
Travel Med Infect Dis. 2018 Nov - Dec;26:58-61
pubmed: 30195006
PLoS Negl Trop Dis. 2016 Jan 06;10(1):e0004315
pubmed: 26734946
PLoS One. 2016 Sep 07;11(9):e0162116
pubmed: 27603669
Parasit Vectors. 2019 Mar 13;12(1):103
pubmed: 30867031
J Clin Virol. 2018 Oct;107:38-47
pubmed: 30176404
Infect Genet Evol. 2017 Jul;51:255-262
pubmed: 28341546
Trends Parasitol. 2013 Sep;29(9):460-8
pubmed: 23916878
Lancet. 2018 Mar 17;391(10125):1108-1120
pubmed: 29179954
Epidemiol Infect. 2017 Mar;145(4):710-714
pubmed: 27903317
Euro Surveill. 2017 Sep;22(39):
pubmed: 29019313
Travel Med Infect Dis. 2013 Sep-Oct;11(5):274-84
pubmed: 23962447
Parasit Vectors. 2016 May 26;9(1):304
pubmed: 27229686
J Travel Med. 2018 Jan 1;25(1):
pubmed: 29669058

Auteurs

Florence Fouque (F)

UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), 20 Avenue Appia, 1211, Geneva, Switzerland. Electronic address: fouquef@who.int.

Valeria Guidi (V)

Laboratory of Applied Microbiology (LMA), University of Applied Sciences and Arts of Southern Switzerland (SUPSI), Via Mirasole 22a, 6500, Bellinzona, Switzerland. Electronic address: valeria.guidi@supsi.ch.

Mario Lazzaro (M)

Ufficio del Medico Cantonale, Department of Public Health and Social Welfare, Via Dogana 16, 6500, Bellinzona, Switzerland. Electronic address: Mario.Lazzaro@ti.ch.

Damiana Ravasi (D)

Laboratory of Applied Microbiology (LMA), University of Applied Sciences and Arts of Southern Switzerland (SUPSI), Via Mirasole 22a, 6500, Bellinzona, Switzerland. Electronic address: damiana.ravasi@supsi.ch.

Gladys Martinetti-Lucchini (G)

Servizio Microbiologia, Diagnostic Microbiology, Department of Laboratory Medicine, Cantonal Hospital Organization, Via Mirasole 22a, 6500, Bellinzona, Switzerland. Electronic address: Gladys.MartinettiLucchini@eoc.ch.

Giorgio Merlani (G)

Ufficio del Medico Cantonale, Department of Public Health and Social Welfare, Via Dogana 16, 6500, Bellinzona, Switzerland. Electronic address: Giorgio.Merlani@ti.ch.

Mauro Tonolla (M)

Laboratory of Applied Microbiology (LMA), University of Applied Sciences and Arts of Southern Switzerland (SUPSI), Via Mirasole 22a, 6500, Bellinzona, Switzerland. Electronic address: mauro.tonolla@supsi.ch.

Eleonora Flacio (E)

Laboratory of Applied Microbiology (LMA), University of Applied Sciences and Arts of Southern Switzerland (SUPSI), Via Mirasole 22a, 6500, Bellinzona, Switzerland. Electronic address: eleonora.flacio@supsi.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH